7,541.00

+50.00

+0.67%

51,003.00

+341.00

+0.67%

29,832.50

+273.75

+0.93%

Russell 2000 Futures

2,905.50

+33.40

+1.16%

16.59

-0.11

-0.66%

4,531.20

+8.00

+0.18%

76,712.26

-618.73

-0.80%

Brent Crude Oil

95.28

-4.93

-4.92%

We are experiencing some temporary issues. The market data on this page is currently delayed.

OTC Markets OTCQB - Delayed Quote USD

Red Light Holland Corp. (TRUFF)

Get top stock picks

0.0290 +0.0010 (+3.57%)

At close: May 22 at 4:00:00 PM EDT

Get top stock picks

Chart Range Bar

AlphaSpace Chart

Loading chart for TRUFF

Previous Close 0.0280
Open 0.0281
Bid 0.0288 x 1198700
Ask 0.0289 x 1000000
Day's Range 0.0281 - 0.0288
52 Week Range 0.0050 - 0.0480
Volume 60,487
Avg. Volume 270,996
Market Cap (intraday) 17.276M
Beta (5Y Monthly) 0.91
PE Ratio (TTM) --
EPS (TTM) -0.0100
Earnings Date (est.) Mar 2, 2026
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

Red Light Holland Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe. The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes. It sells its products under the iMicrodose, Maka, Happy Caps, and Mistercap's brands through brick-and-mortar SmartShops, as well as through online stores. Red Light Holland Corp. is based in Toronto, Canada.

--

Full Time Employees

March 31

Fiscal Year Ends

Sector

Drug Manufacturers - Specialty & Generic

Industry

Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechanism Research

Red Light Holland Announces Shareholder Approval of Name Change and Announces Voting Results from 2026 Annual General and Special Meeting of Shareholders

Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intellectual Property

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions

Red Light Holland Announces Intention to Rebrand

Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution

Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution

Red Light Holland Announces Filament Health Obtains Final Order for Proposed Arrangement

Red Light Holland Announces Filament Health Shareholder Approval of Acquisition

Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments

3 Promising TSX Penny Stocks With Market Caps Up To CA$100M

3 Promising TSX Penny Stocks With Market Caps Up To CA$100M

Trailing total returns as of 5/25/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

TRUFF

70.59%

S&P/TSX Composite index (^GSPTSE)

9.30%

1-Year Return

TRUFF

38.10%

S&P/TSX Composite index (^GSPTSE)

34.59%

3-Year Return

TRUFF

52.46%

S&P/TSX Composite index (^GSPTSE)

76.14%

5-Year Return

TRUFF

88.16%

S&P/TSX Composite index (^GSPTSE)

78.03%

Earnings Per Share

No Earnings Per Share available for this ticker

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q2 FY23

Revenue 736.43k

Earnings -1.31M

Q3

FY22

Q4

FY22

Q1

FY23

Q2

FY23

-2M

-1M

-500K

0

500K

Valuation Measures

  
  
 Annual 

As of 5/22/2026

Market Cap

15.17M
Enterprise Value

9.15M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

3.92
Price/Book (mrq)

1.61
Enterprise Value/Revenue

3.02
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

-119.24%
Return on Assets (ttm)

-13.57%
Return on Equity (ttm)

-31.36%
Revenue (ttm)

4.17M
Net Income Avi to Common (ttm)

-4.97M
Diluted EPS (ttm)

-0.0100

Balance Sheet and Cash Flow

Total Cash (mrq)

9.88M
Total Debt/Equity (mrq)

11.02%
Levered Free Cash Flow (ttm)

-3.32M

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Red Light Holland Corp.

0.0290

+3.57%

Mkt Cap 17.276M

Industry Drug Manufacturers—Specialty & Generic

Medexus Pharmaceuticals Inc.

2.9000

+1.58%

Mkt Cap 95.196M

Industry Drug Manufacturers—Specialty & Generic

C21 Investments Inc.

0.2500

-1.57%

Mkt Cap 29.478M

Industry Drug Manufacturers—Specialty & Generic

Pharmadrug Inc.

0.0100

0.00%

Mkt Cap CAD 1.342M

Industry Drug Manufacturers—Specialty & Generic

Revive Therapeutics Ltd.

0.0220

-4.35%

Mkt Cap 9.585M

Industry Drug Manufacturers—Specialty & Generic

Ovation Science Inc.

0.0250

0.00%

Mkt Cap CAD 960,292

Industry Drug Manufacturers—Specialty & Generic

Cann Group Limited

0.0039

0.00%

Mkt Cap 6.339M

Industry Drug Manufacturers—Specialty & Generic

Malin Corporation plc

6.40

0.00%

Mkt Cap 27.687M

Industry Drug Manufacturers—Specialty & Generic

James E. Wagner Cultivation Corporation

0.0001

0.00%

Mkt Cap 10,942

Industry Drug Manufacturers—Specialty & Generic

Jiuzhitang Co., Ltd.

8.07

-1.47%

Mkt Cap CNY 6.907B

Industry Drug Manufacturers—Specialty & Generic

Stem Holdings, Inc.

0.0001

0.00%

Mkt Cap 666

Industry Drug Manufacturers—Specialty & Generic

MYCOF Noveris Health Sciences Inc.

1.0760 -0.37%

RVVTF Revive Therapeutics Ltd.

0.0220 -4.35%

TRIP.CN Red Light Holland Corp.

0.0350 0.00%

HAVLF HAVN Life Sciences Inc.

0.0001 0.00%

EHVVF EHAVE, Inc.

0.0010 0.00%

Mobilize your Website

View Site in Mobile | Classic

Share by: